Ajanta Pharmaceuticals share price
Ajanta Pharmaceuticals is trading 6.63% upper at Rs 2,690.00 as compared to its last closing price. Ajanta Pharmaceuticals has been trading in the price range of 2,717.25 & 2,507.00. Ajanta Pharmaceuticals has given 21.45% in this year & 8.37% in the last 5 days.
Ajanta Pharmaceuticals has TTM P/E ratio 34.42 as compared to the sector P/E of 29.10.There are 9 analysts who have initiated coverage on Ajanta Pharmaceuticals. There are 3 analysts who have given it a strong buy rating & 3 analysts have given it a buy rating. 1 analysts have given the stock a sell rating.
The company posted a net profit of 245.77 Crores in its last quarter.
Listed peers of Ajanta Pharmaceuticals include IPCA Laboratories (1.30%), Syngene International (1.51%), Ajanta Pharmaceuticals (6.63%) etc.
Ajanta Pharmaceuticals has a 66.27% promoter holding & 33.73% public holding.The Mutual Fund holding in Ajanta Pharmaceuticals was at 2.20% in 30 Jun 2024. The MF holding has increased from the last quarter. The FII holding in Ajanta Pharmaceuticals was at 8.36% in 30 Jun 2024. The FII holding has decreased from the last quarter.
Ajanta Pharmaceuticals share price range
|
| ||||
|
| ||||
Ajanta Pharmaceuticals share Key Metrics
Market Cap ( ₹ Cr.) | 31,603.48 | ||||||||||||||||||
|
|
Ajanta Pharmaceuticals stock Analysis
1 Week | 8.37% |
3 Months | 14.22% |
6 Month | 19.85% |
YTD | 21.45% |
1 Year | 50.41% |
- 28%Balanced risk
- 28%Balanced risk
- 28%Balanced risk
- 28%Balanced risk
- 28%Balanced risk
- Strong Sell
- Sell
- Hold
- Buy
- Strong Buy
Ratings | Current | 1 W Ago | 1 M Ago | 3 M Ago |
---|---|---|---|---|
Strong Buy | 3 | 3 | 3 | 5 |
Buy | 3 | 3 | 3 | 2 |
Hold | 1 | 1 | 1 | 1 |
Sell | 1 | 1 | 1 | 1 |
Strong Sell | 1 | 1 | 1 | 1 |
Total | 9 | 9 | 9 | 10 |
Technical Trends
Long TermConsiders price movement over the last 6 months
Short TermConsiders price movement over the last 1-2 weeks
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Ajanta Pharmaceuticals share price news
Glenmark, JB Pharma, Ajanta, Zydus, Sanofi lead Indian Pharma Market growth during May'2024
2 min read .01:28 PM ISTAjanta Pharmaceuticals Financials
- INCOME
- BALANCE SHEET
- Cashflow
Period | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
Total Revenue | 4,208.71 | 3,742.64 | 3,340.99 | 2,889.69 |
Selling/ General/ Admin Expenses Total | 900.34 | 1,774.38 | 1,481.72 | 1,171.06 |
Depreciation/ Amortization | 135.40 | 130.31 | 124.82 | 115.60 |
Other Operating Expenses Total | 1,069.86 | 40.13 | 35.39 | 27.91 |
Total Operating Expense | 3,172.17 | 3,062.04 | 2,533.12 | 2,005.01 |
Operating Income | 1,036.54 | 680.60 | 807.87 | 884.68 |
Net Income Before Taxes | 1,113.93 | 745.25 | 909.48 | 900.18 |
Net Income | 816.17 | 587.98 | 712.69 | 653.87 |
Diluted Normalized EPS | 64.77 | 46.27 | 55.44 | 50.60 |
Ajanta Pharmaceuticals forecast
Ajanta Pharmaceuticals Technical
5 Day 2,390.19 |
10 Day 2,330.31 |
20 Day 2,287.07 |
50 Day 2,338.77 |
100 Day 2,254.16 |
300 Day 2,123.82 |
Aditya Birla Sun Life Pharma & Healthcare Fund Regular Growth
WhiteOak Capital Pharma and Healthcare Fund Regular Growth
Ajanta Pharmaceuticals Corporate actions
- Board Meetings
- AGM
- Dividends
- Bonus
- Split
- Rights
Meeting Date | Purpose |
30-Jul-24 | Quarterly Results |
02-May-24 | Audited Results & Buy Back of Shares |
31-Jan-24 | Quarterly Results & 2nd Interim Dividend |
31-Oct-23 | Quarterly Results |
27-Jul-23 | Quarterly Results |
05-May-23 | Audited Results |
10-Mar-23 | Buy Back of shares |
01-Feb-23 | Quarterly Results |
03-Nov-22 | Quarterly Results & Interim Dividend |
28-Jul-22 | Quarterly Results |
Meeting Date | Announcement On | Purpose |
18-Jul-23 | 05-May-23 | AGM |
11-Mar-23 | 07-Feb-23 | POM |
04-Aug-22 | 21-Jun-22 | AGM |
14-Jul-21 | 03-Jun-21 | AGM |
- | 28-Dec-21 | Others |
- | 10-Mar-23 | Others |
Announcement On | Record Date | Ex-Dividend | Dividend Value |
25-Jan-24 | 08-Feb-24 | 08-Feb-24 | 26 |
24-Jul-23 | 04-Aug-23 | 04-Aug-23 | 15 |
25-Jul-23 | 04-Aug-23 | 04-Aug-23 | 10 |
02-Nov-22 | 14-Nov-22 | 11-Nov-22 | 7 |
21-Oct-21 | 10-Nov-21 | 09-Nov-21 | 9.5 |
Announcement Date | Record Date | Ex-Bonus | Description |
10-May-22 | 23-Jun-22 | 22-Jun-22 | Bonus issue in the ratio of 1:2 of Rs. 2/-. |
Ajanta Pharmaceuticals Company profile
ABOUT Ajanta Pharmaceuticals
- Industry Biotechnology & Drugs
- ISIN INE031B01049
- BSE Code 532331
- NSE Code AJANTPHARM
Ajanta Pharma Limited is an India-based specialty pharmaceutical company. The Company provides a comprehensive range of specialty branded generic products targeting a broad range of chronic and acute therapies. The Company is engaged in the manufacturing and sale of branded generic and generic pharmaceutical products. It has a wide range of therapeutic segments, such as cardiology, anti-diabetes, ophthalmology, dermatology, antibiotic, anti-malarial, pain, respiratory, gynecology, pediatric and general health products. Its branded generics business is spread across India, the rest of Asia, and Africa. Its business also consists of two verticals: United States generics and institutional business in Africa. Its ophthalmology products include Bimat (anti glaucoma), Nepaflam (anti-inflammatory), Softdrops (lubricant), and Olopat (anti-allergic). The Company's cardiology products include MET XL, Atorfit CV, Antihypertensive Cinod, Rosutor Gold, Dapalex and Vilatin.
Ajanta Pharmaceuticals Management
- Madhusudan Agrawal Executive Vice Chairman of the Board
- Arvind Agrawal Chief Financial Officer
- Gaurang Shah Vice President - Legal, Company Secretary
- Rajesh Agrawal Joint Managing Director, Executive Director
- Yogesh Agrawal Managing Director, Executive Director
FAQs about Ajanta Pharmaceuticals share price
Ajanta Pharmaceuticals Quick Links
Ajanta Pharmaceuticals Dividend Ajanta Pharmaceuticals Bonus Ajanta Pharmaceuticals News Ajanta Pharmaceuticals AGM Ajanta Pharmaceuticals Rights Ajanta Pharmaceuticals Splits Ajanta Pharmaceuticals Board Meetings Ajanta Pharmaceuticals Key Metrics Ajanta Pharmaceuticals Shareholdings Ajanta Pharmaceuticals Profit Loss Ajanta Pharmaceuticals Balance Sheet Ajanta Pharmaceuticals Cashflow Ajanta Pharmaceuticals Q1 Results Ajanta Pharmaceuticals Q2 Results Ajanta Pharmaceuticals Q3 Results Ajanta Pharmaceuticals Q4 Results
Equity Quick Links
Top GainersTop LosersIndian IndicesBSE Active StocksNSE Active Stocks